Health & Biotech
Health Check: Amplia shares surge on pancreatic cancer trial results; Immutep offers hope
Orthocell grows US distributors for nerve repair product to 12
Biocurious: With its ‘molecular Lego’ approach, Arovella is building hope for cancer patients one brick at a time
Lumos secures iMedical US$126k purchase order for FebriDx respiratory tests
Health Check: Compumedics claims world first ‘kids eat for free’ brain scanning breakthrough
Compumedics achieves world-first brain imaging breakthrough
Cell Therapies at Peter Mac powers ASX cancer plays
Optiscan and Mayo Clinic advance digital imaging tech for robotic breast cancer surgery
Health Check: To chagrin of short sellers, Polynovo shares soar on type 1 diabetes breakthrough
Dr Boreham’s Crucible: The wheels keep turning for Dimerix and its kidney drug candidate
Tryptamine names global pharmaceutical leader as chairman
Orthocell gains approval in key Hong Kong market for flagship nerve repair product
Health Check: Greenland and Canada can wait; Trump declares war on drug prices instead
Scott Power: ASX health stocks fall but quarterly reporting was ‘overall positive’
ASX medtechs transforming brain diagnostics for better outcomes
Health Check: Neuren says more patients are staying the course as US Daybue sales lift
Hungarian hospital debuts Imricor’s MRI-guided mapping technology
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
